CTEV Claritev Corporation
$23.67▼ -1.38%
Healthcare
Other
Volume 49.3K
Avg Volume (10D) 272.1K
Key Metrics & Fundamentals
Market Cap
$401.15M
P/E Ratio
–
Div Yield
0.00%
52W Range
11.50 - 73.68
% vs 50 MA
-17.94%
% vs 200 MA
-6.62%
RSI-14
46.7
MACD Histogram
+0.4100
Beta (1Y vs SPY)
2.38
Free Cash Flow
$54.59M
Gross Rev
$257.48M
Gross Profit
$173.30M
EBITDA
$144.43M
COGS
$84.18M
Operating Exp
$140.33M
Operating Income
$32.97M
EBIT
$32.97M
Pretax Income
-$76.65M
Net Income
-$59.23M
EPS (Diluted)
-3.49
Price & Volume History
Loading chart…
Recent News
Claritev Introduces Transparency-Based Pricing, Turning Complex Public Market Data into Actionable Reimbursement Intelligence
GlobeNewswire · Oct 29, 2026 10:30 AM ET
Omnicell (OMCL) Q3 Earnings and Revenues Top Estimates
Zacks · Oct 29, 2026 6:45 AM ET
Claritev Corporation (CTEV) Surges 5.2%: Is This an Indication of Further Gains?
Zacks · Oct 28, 2026 8:24 AM ET
Claritev Appoints Jennifer Main to its Board of Directors
GlobeNewswire · Oct 15, 2026 9:00 AM ET
Claritev Corporation Announces Third Quarter 2026 Earnings Conference Call
GlobeNewswire · Oct 14, 2026 8:00 AM ET
Should You Buy, Hold or Sell Tempus AI Stock Amid AI Boom?
Zacks · Oct 9, 2026 8:51 AM ET
Claritev Selected by GDIT to Support CDC’s World Trade Center Health Program
Business Wire · Sep 22, 2026 9:00 AM ET
Claritev Releases 2025 Corporate Responsibility Report
Business Wire · Sep 17, 2026 9:00 AM ET
Claritev Appoints Ben Letham to its Board of Directors
Business Wire · Sep 15, 2026 9:00 AM ET
Claritev Cares Helps Rural Patients Get Critical Care Closer to Home
Business Wire · Sep 10, 2026 9:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CTEV's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.